189 related articles for article (PubMed ID: 28666995)
21. Structural prediction of the interaction of the tumor suppressor p27
Li J; Vervoorts J; Carloni P; Rossetti G; Lüscher B
BMC Bioinformatics; 2017 Jan; 18(1):15. PubMed ID: 28056778
[TBL] [Abstract][Full Text] [Related]
22. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
[TBL] [Abstract][Full Text] [Related]
23. The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis.
McAndrew CW; Gastwirt RF; Donoghue DJ
Cell Cycle; 2009 Jan; 8(1):66-75. PubMed ID: 19106603
[TBL] [Abstract][Full Text] [Related]
24. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
25. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
26. Nuclear accumulation of cyclin E/Cdk2 triggers a concentration-dependent switch for the destruction of p27Xic1.
Swanson C; Ross J; Jackson PK
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7796-801. PubMed ID: 10884410
[TBL] [Abstract][Full Text] [Related]
27. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
28. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
29. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
30. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
32. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
Pan MH; Chen WJ; Lin-Shiau SY; Ho CT; Lin JK
Carcinogenesis; 2002 Oct; 23(10):1677-84. PubMed ID: 12376477
[TBL] [Abstract][Full Text] [Related]
33. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
Schulze-Gahmen U; Jung JU; Kim SH
Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
[TBL] [Abstract][Full Text] [Related]
36. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
[TBL] [Abstract][Full Text] [Related]
37. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.
Grimmler M; Wang Y; Mund T; Cilensek Z; Keidel EM; Waddell MB; Jäkel H; Kullmann M; Kriwacki RW; Hengst L
Cell; 2007 Jan; 128(2):269-80. PubMed ID: 17254966
[TBL] [Abstract][Full Text] [Related]
38. Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27(Kip1).
Bienkiewicz EA; Adkins JN; Lumb KJ
Biochemistry; 2002 Jan; 41(3):752-9. PubMed ID: 11790096
[TBL] [Abstract][Full Text] [Related]
39. CDK activation by non-cyclin proteins.
Nebreda AR
Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
[TBL] [Abstract][Full Text] [Related]
40. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury.
Park SK; Kim W; Lee CH; Koh GY
Nephron; 2000 Nov; 86(3):306-14. PubMed ID: 11096288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
